FDA approves Roche's Herceptin for gastric cancer

10/20/2010 | Reuters

The FDA has approved the use of Roche Holding's Herceptin with chemotherapy for advanced HER2-positive stomach cancer. The approval was based on a pivotal study showing that the drug combination extended survival compared with chemotherapy alone.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ